Cardio-oncology & other

Low Utilization of Lead Extraction Among Patients With Infective Endocarditis and Implanted Cardiac Electronic Devices

J Am Coll CardiolPublished Retrospective cohort study

Authors' conclusion

Utilization of lead extraction among patients with CIEDs and endocarditis is low, even in the presence of low rates of procedural complications. Lead extraction management is associated with significantly lower mortality, and its use has trended upward between 2016 and 2019.

Study context

Population
Admissions for patients with cardiac implantable electronic device (CIEDs) and infective endocarditis, US, 2016–2019
Participants
25,303 admissions
Exposure
TLE vs no TLE
Outcome
Utilization of TLE
Methodological detailsNationwide Readmissions Database, propensity score matching
  • Nationwide Readmissions Database
  • Propensity score matching

Main finding

As reported in the abstract

Admissions managed with TLE

Managed with TLE

11.5%

TLE use 2016 vs 2019

7.6% vs 14.9%; P trend < 0.001

Observational data: associations, not effects.

Further findings

OutcomeTLENo TLEAdjusted OR (95% CI)
Index mortalityMultivariable logistic regression6.0%9.5%0.47 (0.37–0.60)
Index mortalityPropensity score matching0.51 (0.40–0.66)
  • Index mortality: unadjusted P < 0.001

Factors associated with TLE

Independently associated with TLE: Staphylococcus aureus infection, ICD, large hospital size
TLE less likely with older age, female sex, dementia, kidney disease

Safety

Procedural complications
2.7%

Original publication

Low Utilization of Lead Extraction Among Patients With Infective Endocarditis and Implanted Cardiac Electronic Devices. J Am Coll Cardiol. Published 2 May 2023. doi:10.1016/j.jacc.2023.02.042

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.